
So many highlights for this year’s #SWOGSpring26 but this takes the cake…#BIOFRONT is activated!! Incredibly excited for this #clinicaltrial for #metastatic #kidneycancer patients. @PBarataMD & team have worked so hard on this, and it shows. @SWOG @SupportingSWOG #GUonc
Pedro C Barata, MD MSc FACP@PBarataMD
Excited to see this highlighted 👇 The gut microbiome may play a meaningful role in kidney cancer outcomes—and we’re now testing this prospectively in the BIOFRONT (S2419) trial. A simple oral intervention (CBM588) + immunotherapy → could reshape how we think about treatment. @UHhospitals @SWOG @montypal @DrVaishampayan @caseccc #KidneyCancer #Oncology #Immunotherapy #Microbiome cleveland.com/medical/2026/0…
English









